Cresset Asset Management »

Intellia Therapeutics shares owned by Cresset Asset Management

Quarter-by-quarter ownership of Intellia Therapeutics (NTLA) shares owned by Cresset Asset Management from 13F filings

Historical chart of Cresset Asset Management investment in Intellia Therapeutics

Jul 2020Jan 2021Jul 2021Jan 2022Jul 2022Jan 2023Jul 2023Jan 2024Jul 2024Jan 202502M4M6M8M20k30k40k50k
Value ($)Share countHistorical NTLA position of Cresset Asset Management Source: stockzoa.comValue ($)Share count

Tip: Access up to 7 years of quarterly data

All positions including Intellia Therapeutics held by Cresset Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Intellia Therapeutics by Cresset Asset Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $497k 24k 20.55
2024-06-30 $642k 29k 22.38
2024-03-31 $698k 25k 27.51
2023-12-31 $688k 23k 30.49
2023-09-30 $640k 20k 31.62
2023-06-30 $805k 20k 40.78
2022-03-31 $1.0M 14k 72.70
2021-12-31 $1.8M 15k 118.28
2021-09-30 $6.1M 45k 134.14
2021-06-30 $8.0M 49k 161.91
2021-03-31 $4.5M 56k 80.27
2020-12-31 $1.8M 32k 54.39
2020-09-30 $599k 30k 19.88
2020-06-30 $330k 16k 21.02